Rite Aid — Presentation (July 2024)
6 slides from Rite Aid's investor presentation, Jul 29, 2024
Slide 1: Discussion Materials
Privileged & Confidential | Prepared at the Request of Counsel | Highly Preliminary and Subject to Material Revision | Subject to FRE 408 July 2024 Prepared at the Request of Counsel | Highly Preliminary and Subject to Material Revision | Subject to FRE 408 Discussion Materials
Slide 2: Emergence Date Availability Sensitivity
2 Prepared at the Request of Counsel | Highly Preliminary and Subject to Material Revision | Subject to FRE 408 Emergence Date Availability Sensitivity $s in MM Excess Avail @ Exit ($s MM) W/E 8/3 W/E 8/31 Comments Prior Availability $ 486 $ 482 Dated 7/12 (-) Borrowing Base - Actuals (4) (6) (-) Bo
Slide 3: Disclaimers
——— ST Disclaimers
Slide 4: Disclaimer
4 Prepared at the Request of Counsel | Highly Preliminary and Subject to Material Revision | Subject to FRE 408 Disclaimer These discussion materials (the “Discussion Materials”) were prepared by Management with the assistance of Alvarez & Marsal North America LLC (“A&M”), Guggenheim Securities, LLC
Slide 5: Prepared at the Request | Subject to FRE This presentation (together with any related
5 Prepared at the Request of Counsel | Highly Preliminary and Subject to Material Revision | Subject to FRE 408 This presentation (together with any related oral commentary and any supplemental materials or updates, this “Presentation” and, together with any associated information and materials prov
Slide 6: Disclaimer (cont.)
6 Prepared at the Request of Counsel | Highly Preliminary and Subject to Material Revision | Subject to FRE 408 Disclaimer (cont.) The information used to prepare this Presentation and any other Materials is based upon industry, business, financial, legal, regulatory, tax, accounting, actuarial and